According to the Mayo Clinic, urinary incontinence — or the loss of bladder control — is a common problem.
The condition ranges in severity, from occasionally leaking urine when you cough or sneeze, to having an urge to urinate so sudden and strong that you don’t get to a toilet in time.
Fortunately, urinary incontinence is a treatable condition. In most cases, simple lifestyle changes or medical treatment can ease discomfort or ...
continue reading...
An entry on investment blog Seeking Alpha says that Johnson & Johnson is still trying to regain its footing after a disastrous series of recalls. But the blog advises investors that big salary cut for former CEO William Weldon, who has been demoted to chairman, is a good sign.
Alex Gorsky, the company’s new CEO, has said he plans to improve quality control at Johnson & Johnson.
Johnson & Johnson has instituted ...
continue reading...
Physicians quoted in an article in Arthritis Today about all-metal hip implants said patients who received the devices should get checked regularly to make sure metal debris known to break off from the devices aren’t causing them any health problems.
The implants, featuring both a head and a socket coated in metal, have been problematic both for their high early failure ...
continue reading...
According to a story in the Washington Post, Johnson & Johnson has applied to the U.S. Food and Drug Administration to get approval of another use for its anti-clotting drug Xarelto.
Johnson & Johnson currently markets Xarelto for reducing the risk of blood clots in patients after knee or hip replacement surgery, and reducing the risk of stroke and other blood clots in people with a type of irregular heartbeat. The ...
continue reading...
A piece in the Denver Post faults the U.S. Food and Drug Administration’s minimal monitoring of medical devices, and says the existing system leads to injuries and deaths from faulty devices allowed to remain on the market.
According to the article, prescription drugs have unique codes that can be used to track problems. But medical devices have no such identifiers and the FDA doesn’t even know how many devices are implanted ...
continue reading...
An NPR report on an Arkansas jury’s billion-dollar decision against Johnson & Johnson mentions that the company is most famous for its baby shampoo and wryly notes: “So much for no more tears.”
The federal court decision was in response to allegations that the company used misleading marketing for its antipsychotic drug Risperdal. The jury found that the company failed to properly disclose the drug’s possible side effects, like weight gain, ...
continue reading...
